BioSpace News Archive

Pharm Country

New Research Finds About Half of Parents Use Cell Phones While Driving with Young Children in the Car

Study of Adults Across the U.S. Also Revealed Risky Behaviors Associated with Distracted Driving

July 12, 2018
·
5 min read
Genetown

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic

Initial programs to focus on immuno-oncology, inflammation and autoimmune disorders

July 12, 2018
·
3 min read
Policy

CStone’s PD-1 inhibitor CS1003 receives clinical trial approval in China

CStone Pharmaceuticals announced that the China National Drug Administration (CNDA) has approved the first clinical trial application (CTA) in China for CS1003

July 12, 2018
·
3 min read
AGC to Expand GMP-Compliant Synthetic Pharmaceutical Intermediate and Active Ingredient Production Capacity Tenfold

Broadened CDMO Business Will Cover Commercial New Drugs As Well As in Development Stage of Ones

July 12, 2018
·
2 min read
Policy

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Acute myeloid leukemia (AML) is one of the most aggressive cancers, with a very low survival rate and few options available for patients who are ineligible for intensive chemotherapy

July 12, 2018
·
14 min read
Policy

Genentech Announces Submission of Supplemental New Drug Application for Venclexta for People With Previously Untreated Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

Venclexta represents a potential new way of treating AML, the most common type of aggressive leukemia in adults

July 12, 2018
·
16 min read
Drug Development

New Preclinical Results on Onxeo’s AsiDNA™, First-in-Class DNA Repair Inhibitor, Point to Strong Synergy and Reversion of Tumor Resistance when combined to PARP inhibitors

AsiDNA™ combined with olaparib* more than doubled the complete response rate observed with olaparib alone in an in vivo model of triple negative breast cancer resistant to PARP inhibitors

July 12, 2018
·
8 min read
Alligator Bioscience AB Interim Report January-June 2018

Positive data for our preclinical projects

July 12, 2018
·
4 min read
Deals

ViaDerma Provides an Update to Shareholders via a Letter from the CEOThe Company is also in early stage discussions to sell its product on TV

ViaDerma, Inc. is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the Company’s website, www.viadermalicensing.com. (Link to CEO Letter)

July 12, 2018
·
1 min read
Business

Maxar Technologies Appoints Biggs Porter as Chief Financial Officer

Maxar Technologies announced the appointment of Biggs Porter as Executive Vice President and Chief Financial Officer, effective August 15, 2018.

July 12, 2018
·
4 min read